Elicio Therapeutics (ELTX) Capital Expenditures (2020 - 2025)
Elicio Therapeutics (ELTX) reported Capital Expenditures of $16000.0 for Q4 2025, down 64.44% on a YoY basis from $45000.0 in Q4 2024, and down 64.44% quarter-over-quarter from $45000.0 in Q4 2024.
Elicio Therapeutics (ELTX) Capital Expenditures (2020 - 2025) Analysis & Trends
Elicio Therapeutics has reported Capital Expenditures for 6 years, with the latest figure at $16000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures fell 64.44% year-over-year to $16000.0; the trailing twelve-month figure through Dec 2025 stood at $61000.0 (down 29.89% YoY), and the FY2025 full-year result was $16000.0, down 81.61% from the prior year.
- Capital Expenditures for Q4 2025 stood at $16000.0, down from $45000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $559000.0 in Q2 2022, with the low at -$342000.0 in Q4 2021.
- Historically, Capital Expenditures has averaged $68916.7 across 5 years, with a median of $43500.0 in 2023.
- The largest YoY upside for Capital Expenditures was 2340.0% in 2021 against a maximum downside of 8650.0% in 2021.
- Elicio Therapeutics' Capital Expenditures stood at -$342000.0 in 2021, then jumped by 127.78% to $95000.0 in 2022, then tumbled by 52.63% to $45000.0 in 2023, then changed by 0.0% to $45000.0 in 2024, then slumped by 64.44% to $16000.0 in 2025.
- The last three Capital Expenditures figures came in at $16000.0 (Q4 2025), $45000.0 (Q4 2024), and $42000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Mar 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Dec 31, 2022 | 95,000.00 |
| Jun 30, 2022 | 559,000.00 |
| Jun 30, 2022 | 559,000.00 |
| Dec 31, 2021 | -342,000.00 |
| Dec 31, 2021 | -342,000.00 |
| Sep 30, 2021 | 61,000.00 |
| Sep 30, 2021 | 61,000.00 |